UGT1A3 Inhibitors [MoA] - N0000191275
Pharmacologic Class Information
Pharmacologic Code | N0000191275 |
Pharmacologic Name | UGT1A3 Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with UGT1A3 Inhibitors
The table contains 6 products whose active ingredient are classified under the same pharmacologic class UGT1A3 Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0078-0684 | Promacta | Non-Proprietary Name: Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-0685 | Promacta | Non-Proprietary Name: Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-0686 | Promacta | Non-Proprietary Name: Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-0687 | Promacta | Non-Proprietary Name: Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-0697 | Promacta | Non-Proprietary Name: Eltrombopag Olamine | Powder, For Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-0972 | Promacta | Non-Proprietary Name: Eltrombopag Olamine | Powder, For Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE |